What is missing from descriptions of treatment in trials and reviews?
By P. Glasziou, Emma Meats, C. Heneghan, S. Shepperd. British medical journal, 2008
610 citations recorded by the source corpus.
Subfields: Economics and Econometrics, General Health Professions, Statistics and Probability
View Paper: https://www.semanticscholar.org/paper/387537a474dc492acf85ffcf959b1860bd1d8417
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Economics and Econometrics
- Douglas G. Altman
- David Moher
- K. F. Schulz
- Matthias Egger
- P. Gøtzsche
- Diana Elbourne
- Susan Michie
- Sally Hopewell
In General Health Professions
- David Moher
- Douglas G. Altman
- K. F. Schulz
- P. Gøtzsche
- Mike Clarke
- J. Tetzlaff
- Matthias Egger
- A. Liberati
In Statistics and Probability
- David Moher
- Douglas G. Altman
- K. F. Schulz
- Matthias Egger
- P. Gøtzsche
- J. Tetzlaff
- Diana Elbourne
- Mike Clarke
Citations in the corpus
- CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials (2010, neutral): “Unfortunately, attempted assessments frequently fail because authors of many trial reports neglect to provide lucid and complete descriptions of that critical information.[2-4]”
- CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. (2012, background): “For drug trials, specifying the phase of the trial (I-IV) may also be relevant.”
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009, background): “For example, poor or incomplete reporting of study designs, patient populations, and interventions may hamper interpretation and synthesis of the included studies [84].”
- Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement (2010, neutral): “55 The authors found that elements of the intervention were missing in half of the published articles that they reviewed, giving insufficient detail, for example, with practitioners unable to use the treatments as described and researchers unable to replicate studies.”
- Guidance for Developers of Health Research Reporting Guidelines (2010, background): “Glasziou and colleagues [1] assessed descriptions of given treatments in 80 trials and systematic reviews for which summaries were published during one year (October 2005 to October 2006) in Evidence-Based Medicine, a journal that is aimed at physicians working in primary care and general medicine.”
- A refined taxonomy of behaviour change techniques to help people change their physical activity and healthy eating behaviours: The CALO-RE taxonomy (2011, background): “Current reporting of interventions in published evaluations falls short of the detail required for reliably identifying intervention content (Dombrowski, Sniehotta, Avenell, & Coyne, 2007 ; Glasziou, Meats, Heneghan, & Shepperd, 2008 ; Michie, Fixen, Grimshaw, & Eccles, 2009 ) and hence limits th”
- Developing and evaluating complex interventions: the new Medical Research Council guidance (2008, neutral): “This has been a weakness of the reporting of complex intervention studies in the past,”